Abstract
Posterior reversible encephalopathy syndrome (PRES) is the most common neurological complication occurring in children undergoing induction chemotherapy for acute lymphoblastic leukaemia (ALL) but is increasingly recognised to occur in adults as well. Here, we report a woman who presented with B-cell ALL (B-ALL) at the time of delivery and developed PRES 1 day after receiving intrathecal (IT) methotrexate (MTX) that rapidly resolved. She subsequently received IT MTX without recurrence of neurological symptoms. This case represents the first case of PRES in a postpartum B-ALL patient receiving IT MTX, demonstrates that re-treatment with MTX in this case could be done safely and highlights the risk of PRES in adults treated for B-ALL.
| Original language | English (US) |
|---|---|
| Article number | bcr-2017-220429 |
| Journal | BMJ case reports |
| Volume | 2017 |
| DOIs | |
| State | Published - 2017 |
Bibliographical note
Publisher Copyright:© BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Keywords
- chemotherapy
- haematology (drugs and medicines)
- haematology (incl blood transfusion)
- pregnancy
- unwanted effects / adverse reactions
